Packaging is a critical component of pharmaceuticals, protecting the integrity, safety, and efficacy of essential treatments throughout the supply chain and providing tools for product traceability. James Bury, director technology, Tjoapack explains.
Commercial director, Rory O’Keeffe, Europlaz, examines the latest innovations that the team believes will be transformative to future clinical pathways.
Life sciences manufacturers continuously strive for accelerated launch, increased capacity for in-demand medicine, enhanced security of supply and improved sustainability.
Niamh Bissett, Director, Operations, PMO, West Pharmaceutical Services discusses Annex 1 and the Impact of Primary Packaging in our latest EPM Online insight.
Justin Wilson, partner and pharmaceuticals & gene therapy sector specialist at European intellectual property law firm Withers & Rogers explores how patent lifecycle management is key for cell and gene therapy innovators.
Dr Maxim Polyakov, Senior Vice President, Business Intelligence and Research at M3 discusses how to use primary market research for robust digital marketing.
Adriano Leuzzi, Head of Process Development and Angelo Raggioli, Head of Technology Development at ReiThera explore the advancements and challenges in bioprocessing for viral-vector gene therapy manufacturing in our latest EPM Online insight.
Dr Sylvain Lacomble, Vice President Europe Middle East & Africa, Terumo Blood and Cell Technologies explores the lifeblood of healthcare: celebrating and maximising blood donations in our latest EPM Online Insight.
Stephan Von Schilcher, global strategic account manager at Systech explores mapping the counterfeit and diversion epidemic in the pharmaceutical industry for out latest EPM Online Insight.
Kerry Pickstone discusses the impact of the new anti-espionage laws in China, weighing how Western pharmaceutical firms can embed resilience into their supply chain strategies and mitigate potential disruption.
